Video

Emerging Psychedelic Therapies

Here's why psychedelics might be a valuable addition to mental health treatment.

Alexander Somjen discusses the fragmented psychedelic industry, regulatory frameworks, and potential commercial success.

Alexander Somjen is the CEO and Director of Origin Therapeutics.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Videos
Psychiatric Times Experts Weight in on FDA Advisory Decision for PTSD
ketamine
New Africa /Adobestock
© 2025 MJH Life Sciences

All rights reserved.